Geron Corporation is a biopharmaceutical company focused on developing and marketing therapeutic and diagnostic products for cancer based on telomerase technology. It also focuses on cell-based therapeutics using through the use human embryonic stem cell technology. In addition to its core oncology and hESC programs, Geron uses intellectual property and other resources to develop, or license others to develop, research and development products and products and services based on nuclear transfer. The company was founded in 1990 and has headquarters in Menlo Park, Calif. Geron also has a subsidiary in Edinburgh, Scotland. Geron s common shares trade on the NASDAQ under the ticker symbol GERN.